Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127180221 | 12718022 | 1 | I | 201604 | 20160825 | 20160906 | 20160906 | PER | US-PFIZER INC-2016406708 | PFIZER | 58.00 | YR | M | Y | 0.00000 | 20160906 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127180221 | 12718022 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | UNK | 71868 | |||||||||||
| 127180221 | 12718022 | 2 | SS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | UNK | 50467 | |||||||||||
| 127180221 | 12718022 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | 11719 | |||||||||||
| 127180221 | 12718022 | 4 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | 71484 | |||||||||||
| 127180221 | 12718022 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | 0 | |||||||||||
| 127180221 | 12718022 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
| 127180221 | 12718022 | 7 | SS | RITUXIMAB | RITUXIMAB | 1 | UNK | 0 | |||||||||||
| 127180221 | 12718022 | 8 | C | ZOVIRAX | ACYCLOVIR | 1 | Oral | 400 MG, 2X/DAY | 0 | 400 | MG | TABLET | BID | ||||||
| 127180221 | 12718022 | 9 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK, AS NEEDED ((90 MCG/ACT HFA AEROSOL)) | 0 | |||||||||||
| 127180221 | 12718022 | 10 | C | DIFLUCAN | FLUCONAZOLE | 1 | Oral | 200 MG, 1X/DAY | 0 | 200 | MG | TABLET | QD | ||||||
| 127180221 | 12718022 | 11 | C | HEPARIN LOCK FLUSH | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | 100 IU/ML, AS NEEDED (SYRINGE 5 ML) | 0 | ||||||||||
| 127180221 | 12718022 | 12 | C | GLUCOPHAGE XR | METFORMIN HYDROCHLORIDE | 1 | Oral | 750 MG, 2X/DAY | 0 | 750 | MG | MODIFIED-RELEASE TABLET | BID | ||||||
| 127180221 | 12718022 | 13 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | 5 DF, AS NEEDED (100 UNIT/ML INSULIN PEN) | 0 | 5 | DF | ||||||||
| 127180221 | 12718022 | 14 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 8 MG, AS NEEDED (EVERY 6 HOURS AS NEEDED) | 0 | 8 | MG | TABLET | |||||||
| 127180221 | 12718022 | 15 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | MODIFIED-RELEASE TABLET | QD | ||||||
| 127180221 | 12718022 | 16 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | Oral | 10 MG, 1X/DAY (AS NEEDED) | 0 | 10 | MG | TABLET | QD | ||||||
| 127180221 | 12718022 | 17 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 10 ML, 2X/DAY (0.9 % SOLUTION 0.9 %) | 0 | 10 | ML | BID | |||||||
| 127180221 | 12718022 | 18 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 DF, 1X/DAY (SULFAMETHOXAZOLE: 400; TRIMETHOPRIM: 80 MG) | 0 | 1 | DF | TABLET | QD | ||||||
| 127180221 | 12718022 | 19 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Oral | 1000 MG, 4X/DAY (2 TABLETS BY MOUTH EVERY 6 HOURS AS NEEDED) | 0 | 1000 | MG | TABLET | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127180221 | 12718022 | 1 | Acute lymphocytic leukaemia |
| 127180221 | 12718022 | 2 | Acute lymphocytic leukaemia |
| 127180221 | 12718022 | 3 | Acute lymphocytic leukaemia |
| 127180221 | 12718022 | 4 | Acute lymphocytic leukaemia |
| 127180221 | 12718022 | 5 | Acute lymphocytic leukaemia |
| 127180221 | 12718022 | 6 | Acute lymphocytic leukaemia |
| 127180221 | 12718022 | 7 | Acute lymphocytic leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127180221 | 12718022 | Acute lymphocytic leukaemia | |
| 127180221 | 12718022 | Disease recurrence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127180221 | 12718022 | 1 | 201511 | 20160325 | 0 | |
| 127180221 | 12718022 | 2 | 201511 | 20160325 | 0 | |
| 127180221 | 12718022 | 3 | 201511 | 20160325 | 0 | |
| 127180221 | 12718022 | 4 | 201511 | 20160325 | 0 | |
| 127180221 | 12718022 | 5 | 201511 | 20160325 | 0 | |
| 127180221 | 12718022 | 6 | 201511 | 20160325 | 0 |